
iBio, Inc. — Investor Relations & Filings
iBio, Inc. is a preclinical-stage biotechnology company that utilizes a proprietary, AI-driven drug discovery platform to develop novel antibody therapeutics. The company focuses on creating next-generation medicines for obesity and cardiometabolic disorders, aiming to enhance metabolic health. Its technology stack integrates artificial intelligence, machine learning, and advanced computational biology to accelerate the discovery and optimization of biopharmaceuticals for difficult-to-drug targets. The company's internal pipeline consists of therapeutic candidates developed using this platform.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 - iBio, Inc. (0001420720) (Filer) | 2026-04-29 | English | |
| 8-K - iBio, Inc. (0001420720) (Filer) | 2026-04-08 | English | |
| 4 - iBio, Inc. (0001420720) (Issuer) | 2026-03-23 | English | |
| 4 - iBio, Inc. (0001420720) (Issuer) | 2026-03-23 | English | |
| 8-K - IBIO, INC. (0001420720) (Filer) | 2026-02-27 | English | |
| S-3 - IBIO, INC. (0001420720) (Filer) | 2026-02-27 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 38584987 | 424B3 - iBio, Inc. (0001420720) (Filer) | 2026-04-29 | English | ||
| 33816158 | 8-K - iBio, Inc. (0001420720) (Filer) | 2026-04-08 | English | ||
| 33012910 | 4 - iBio, Inc. (0001420720) (Issuer) | 2026-03-23 | English | ||
| 33012908 | 4 - iBio, Inc. (0001420720) (Issuer) | 2026-03-23 | English | ||
| 32891626 | 8-K - IBIO, INC. (0001420720) (Filer) | 2026-02-27 | English | ||
| 32891629 | S-3 - IBIO, INC. (0001420720) (Filer) | 2026-02-27 | English | ||
| 29659150 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29659058 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29658712 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32891630 | 10-Q - IBIO, INC. (0001420720) (Filer) | 2026-02-10 | English | ||
| 32891628 | 8-K - IBIO, INC. (0001420720) (Filer) | 2026-02-10 | English | ||
| 19423077 | EFFECT - iBio, Inc. (0001420720) (Filer) | 2026-02-10 | English | ||
| 18510814 | 424B3 - iBio, Inc. (0001420720) (Filer) | 2026-02-09 | English | ||
| 32891624 | 4 - IBIO, INC. (0001420720) (Filer) | 2026-01-30 | English | ||
| 32891625 | 4 - IBIO, INC. (0001420720) (Filer) | 2026-01-30 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Biosynex
Designs and distributes medical diagnostic solutions, inclu…
|
ALBIO | FR | Manufacturing |
|
BioSyntech, Inc.
Develops advanced biotherapeutic thermogels for tissue repa…
|
BSYI | CA | Manufacturing |
|
BIO-TECHNE Corp
Global supplier of reagents and instruments for research an…
|
TECH | US | Manufacturing |
|
Bioten Co., Ltd
Develops and manufactures natural health foods, cosmetics, …
|
289170 | KR | Manufacturing |
|
Biotest AG
Develops and supplies plasma protein products and biotherap…
|
BIO3 | DE | Manufacturing |
|
Bio-Thera Solutions, Ltd.
Develops innovative therapeutics and biosimilars for oncolo…
|
688177 | CN | Manufacturing |
|
Biotika A.S.
A biotechnology company that manufactures APIs for human an…
|
BSL | SK | Manufacturing |
|
Bioton S.A.
A global manufacturer of recombinant human insulin and diab…
|
BIO | PL | Manufacturing |
|
BIOVENTIX PLC
Develops and supplies sheep monoclonal antibodies for clini…
|
BVXP | GB | Manufacturing |
|
Bioversys N
Clinical-stage biopharma developing antibacterial therapies…
|
BIOV | CH | Manufacturing |
iBio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35045/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35045 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35045 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35045 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35045}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for iBio, Inc. (id: 35045)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.